Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
New stent method may fix Hard-to-Treat aortic aneurysms
Disease control OngoingThis study looks at a special stent technique (called ChEVAR) for people with a type of abdominal aortic aneurysm that is hard to treat because the aneurysm starts close to the kidney arteries. The goal is to see if this method is safe and works well in everyday medical practice.…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 17, 2026 07:24 UTC
-
Heart valve showdown: TAVI vs. surgery for aortic stenosis
Disease control OngoingThis study compares two ways to replace a narrowed heart valve in people with severe aortic stenosis who are at intermediate risk for surgery. About 1,700 participants were randomly assigned to get either a less invasive catheter-based valve (TAVI) or traditional open-heart surge…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 17, 2026 07:22 UTC
-
New heart valve fix without open surgery shows promise for Low-Risk patients
Disease control OngoingThis study tests a less invasive procedure called TAVR against traditional open-heart surgery for people with severe aortic stenosis who are at low risk for surgery. About 2,200 participants will be followed for two years to see if TAVR is as safe and effective as surgery in prev…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 17, 2026 07:20 UTC
-
New heart valve device offers hope for High-Risk patients in china
Disease control OngoingThis study tests a new heart valve device (CoreValve Evolut PRO) in 52 Chinese patients with severe aortic stenosis who are too high-risk for open-heart surgery. The valve is inserted through a tube in the artery, avoiding major surgery. Researchers are checking how many patients…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New Catheter-Based valve offers hope for High-Risk heart patients
Disease control OngoingThis study tests a new device called the Intrepid Transcatheter Mitral Valve Replacement System in 128 people with severe mitral regurgitation who are too high-risk for open-heart surgery. The valve is delivered through a catheter via a vein in the leg, avoiding a large incision.…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 11, 2026 20:40 UTC